autologous

Search by Month

Search by Year

Biotech & MedTech

Hemostemix CEO on ACP’s Response to Ischemia in the Circulatory System

In a recent InvestorIntel interview, Peter Clausi speaks with Thomas Smeenk, Co-Founder, President and CEO of Hemostemix Inc.…

InvestorNews

January 19, 2021
No Comments
Biotech & MedTech

Co-founder Thomas Smeenk on the benefits of Hemostemix autologous stem cell therapy

In a recent InvestorIntel interview, Peter Clausi speaks with Thomas Smeenk, Co-Founder, President and CEO of Hemostemix Inc.…

InvestorNews

January 12, 2021
No Comments

InvestorNews Interviews

View All

Quantum eMotion CEO Francis Bellido Expands U.S. Team and Advanced Cybersecurity Initiatives

April 21, 2025

Ucore CEO Pat Ryan Warns of Geopolitical Risks and Urges North American Collaboration on Critical Rare Earth Supply Chains in Interview with Jack Lifton

April 16, 2025

Nerds On Site CEO Warns Businesses on Data Risks from Public LLMs like ChatGPT, Highlights Revolutionary Cybersecurity Solution and Strategic Growth Initiatives

April 15, 2025

Mid Atlantic Capital’s Charlie Flynn Unveils Proven Blueprint for Uncovering Undervalued Market Gems

April 10, 2025